Finance

Lists
Q3 2026 earnings • released • EPS beat +28.67% • Revenue beat +1.81%
See results
CURA:TSE
Curaleaf Holdings Inc
CA$13.22
-1.34%
(-0.18) 1D
Nov 5, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for CURA...
Open
CA$13.35
High
CA$13.50
Low
CA$12.87
Mkt. cap
3.09B
Avg. vol.
307.58K
Volume
514.95K
52-wk high
CA$20.92
52-wk low
CA$7.77
EPS
-CA$0.06
Shares outstanding
233.67M
No. of employees
6K
Open
CA$13.35
High
CA$13.50
Low
CA$12.87
Mkt. cap
3.09B
Avg. vol.
307.58K
Volume
514.95K
52-wk high
CA$20.92
52-wk low
CA$7.77
EPS
-CA$0.06
Shares outstanding
233.67M
No. of employees
6K
News stories
From web sources and news partners
About Curaleaf Holdings Inc
CEO-
Employees5.55K
Founded2014
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitecuraleaf.com
Last report
Nov 4, 2026
Fiscal period
Q3 2026
-$0.11 / -$0.15
+28.67%beat
Revenue / Est. (USD)
352.65M / 346.39M
+1.81%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
320.24M
323.36M
324.23M
340.10M
Cost of goods sold
160.50M
159.81M
166.94M
170.18M
Cost of revenue
160.50M
159.81M
166.94M
170.18M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
110.18M
105.76M
113.21M
131.68M
Operating expense
155.71M
153.25M
156.54M
165.69M
Total operating expenses
316.21M
313.06M
323.48M
335.88M
Operating income
4.03M
10.31M
753.00K
4.22M
Other non operating income
1.33M
2.84M
1.23M
1.51M
EBT including unusual items
-24.31M
-16.74M
-28.63M
-26.31M
EBT excluding unusual items
-21.01M
-11.25M
-24.88M
-24.51M
Income tax expense
30.24M
25.22M
-98.70M
-38.78M
Effective tax rate
-124.40%
-150.58%
344.77%
147.42%
Other operating expenses
-
-
-
-
Net income
-57.03M
-59.82M
69.80M
12.51M
Net profit margin
-17.81%
-18.50%
21.53%
3.68%
Earnings per share
-0.19
-0.15
0.29
0.07
Interest and investment income
151.00K
174.00K
212.00K
149.00K
Interest expense
-25.36M
-24.50M
-25.53M
-27.72M
Net interest expenses
-25.21M
-24.32M
-25.32M
-27.57M
Depreciation and amortization charges
35.24M
35.14M
33.67M
34.02M
EBITDA
53.50M
58.37M
48.61M
52.83M
Gain or loss from assets sale
1.22M
499.00K
-194.00K
194.00K
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps